HealthCCSng vs EchoNext

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

HealthCCSng

by Nano-X AI

EchoNext

by Pathway Labs

AI Verdict

HealthCCSng and EchoNext are adjacent tools in cardiology AI, both aiming to improve early detection of heart disease, but they utilize different diagnostic modalities. HealthCCSng analyzes CT scans to detect and quantify coronary artery calcification, indicating risk for coronary artery disease. EchoNext, on the other hand, analyzes ECGs to detect hidden structural heart disease, including heart failure and valve disease.

Choose HealthCCSng if…

Choose HealthCCSng if your primary goal is to opportunistically identify patients at risk of coronary artery disease by analyzing existing routine CT scans. This tool excels at automatically detecting and quantifying coronary artery calcification (CAC) from non-contrast, non-ECG gated chest CTs, integrating seamlessly into existing radiology workflows to provide a calcium score and categorization.

View HealthCCSng →

Choose EchoNext if…

Choose EchoNext if you need an AI-powered solution to screen for hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension, using standard 12-lead ECGs. This tool is ideal for early detection in a broad patient population, potentially identifying high-risk individuals who may benefit from further diagnostic imaging like echocardiograms.

View EchoNext →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	HealthCCSng	EchoNext
Pricing	Not publicly available	Starts at $600/month
Deployment	Cloud-based, integrates with PACS and EMR systems	Available through the OpenEvidence clinical decision support platform.
BAA Available	Unknown	Yes AI-estimated
FDA Status	Yes AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

HealthCCSng

HealthCCSng offers an automated workflow that seamlessly integrates with existing PACS and EMR systems, providing results without human intervention. This suggests a streamlined user experience for radiologists and cardiologists. EchoNext, while available through a clinical decision support platform, still requires physicians to submit ECGs for analysis, which might introduce an extra step in the workflow.

Clinical Value

EchoNext

EchoNext has demonstrated superior accuracy in detecting structural heart disease from ECGs compared to cardiologists, even those assisted by AI. It was trained on a significantly larger dataset of ECG-echocardiogram pairs and has been validated in multi-site studies across numerous hospitals. HealthCCSng effectively identifies patients at risk of coronary artery disease from CT scans, but the comparative performance against human experts or the breadth of conditions detected is less extensively detailed in the provided information.

Pricing & Value

EchoNext

EchoNext provides transparent tiered pricing starting at $600/month, with discounts for annual plans and add-ons for premium features. HealthCCSng's pricing is not publicly available, requiring direct contact with the vendor. This lack of transparency makes it difficult to assess its value proposition.

Enterprise Readiness

Tie

Both tools are FDA-cleared and HIPAA compliant, indicating a strong foundation for enterprise deployment. HealthCCSng integrates with PACS and EMR systems, while EchoNext is available through the OpenEvidence clinical decision support platform, which is used by a large number of U.S. physicians. Both demonstrate capabilities for integration into existing healthcare workflows.

Innovation

EchoNext

EchoNext represents a significant innovation by enabling the detection of a broad range of hidden structural heart diseases from routine ECGs, a widely available and inexpensive test. This expands the diagnostic potential of ECGs beyond their traditional uses. HealthCCSng's innovation lies in opportunistically detecting coronary artery calcification from routine CT scans, which is valuable but builds upon existing imaging modalities.

Support & Docs

Tie

Neither tool provides specific details about their support and documentation offerings in the provided information. While both are FDA-cleared products from established companies, without further details, it is not possible to distinguish between them on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	HealthCCSng	EchoNext
Tool Name	HealthCCSng	EchoNext
Company	Nano-X AI	Pathway Labs
Description	FDA-cleared AI-powered solution that analyzes routine CT scans to automatically detect and quantify coronary artery calcification (CAC), identifying patients at risk of coronary artery disease.	FDA-cleared AI tool from Pathway Labs that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension.
Analyzes	Routine CT scans (non-contrast, non-ECG gated chest CT scans)	Standard 12-lead ECGs
Key Detections	Coronary artery calcification (CAC), categorizes into 'zero', 'low', 'moderate', and 'severe' CAC categories, generates numerical calcium score, provides visualization of calcified plaques.	Hidden structural heart disease, heart failure risk, valve disease, pulmonary hypertension indicators.
Specialties	Cardiology, Radiology	Cardiology, Family Medicine, Hospital Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring HealthCCSng and EchoNext.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems?

HealthCCSng is designed for seamless integration with PACS and EMR systems, providing automated workflow for results without human intervention, and its output is available to radiologists as part of their standard workflow. EchoNext integrates with the OpenEvidence clinical decision support platform, which is used by many physicians, allowing its screening output to be directly accessible within a tool many physicians already use during patient visits, rather than requiring a separate workflow.

What is the accuracy and sensitivity of each tool in detecting cardiac conditions?

EchoNext demonstrated higher accuracy in detecting structural heart problems from ECGs, correctly identifying 77% compared to cardiologists' 64% in a 2025 study. HealthCCSng automatically detects and quantifies coronary artery calcification (CAC) from routine CT scans, which is a strong predictor of future cardiac events, with patients in the highest category being over 20 times more likely to suffer an event.

What is the learning curve for physicians to effectively use each tool?

HealthCCSng provides automated detection and categorization of CAC, with customizable configurations, suggesting a relatively straightforward learning curve for interpreting the output within existing radiology workflows. EchoNext analyzes standard ECGs to flag high-risk patients for structural heart disease, and its integration with the OpenEvidence platform aims to make it easily accessible within familiar physician tools, potentially reducing the learning curve for its use in identifying patients who need further evaluation.

What kind of clinical impact can be expected from implementing these tools?

HealthCCSng can identify previously undetected cardiovascular risks from routine CT scans, enabling physicians to route patients with high CAC levels to appropriate preventive care and treatment. EchoNext can detect hidden structural heart disease earlier, potentially improving early detection and helping to rule out unnecessary echocardiograms for low-risk patients.

What are the audit-trail features of each tool?

While specific audit-trail features are not detailed for HealthCCSng, its integration with PACS and EMR systems suggests that its results would be part of the patient's electronic record, which typically includes audit functionalities. For EchoNext, the integration with OpenEvidence, a clinical decision support platform, implies that its outputs and any associated physician actions would likely be logged within that platform, contributing to an audit trail.

How do these tools support multi-site rollout and scalability?

HealthCCSng's cloud-based deployment and seamless integration with PACS and EMR systems suggest it is designed for scalability across different healthcare environments. EchoNext is available through the OpenEvidence platform, which is used by a large number of U.S. clinicians, indicating a design for broad access and multi-site deployment, from major hospitals to community practices.